Follow Reference Alonso J. Córdoba J. Rovira A. (2014). Brain magnetic resonance in hepatic encephalopathy. Seminars in Ultrasound . CT and MRI, 35(2), 136–152.24745889 Follow Reference Amodio P. Montagnese S. Gatta A. Morgan M. Y. (2004). Characteristics of minimal hepatic encephalopathy.Metabolic Brain Disease, 19(3/4), 253–267. 10.1023/B:MEBR.0000043975.01841.de15554421 Follow Reference Apetauerova D. Hildebrand P. Scala S. Zani J. W. Lipert L. Clark E. Fennell T. Gordon F. D. (2021). A prospective study of the prevalence of parkinsonism in patients with liver cirrhosis.Hepatology Communications, 5(2), 323–333. 10.1002/hep4.162433553978 Follow Reference Awada A. Sullivan S. Palkar V. Sbeih F. Naufal R. Al Rajeh S. (1995). Brain magnetic resonance imaging in non-alcoholic cirrhosis.European Journal of Radiology, 21(2), 84–88. 10.1016/0720-048X(95)00694-L8850497 Follow Reference Bergeron M. Reader T. A. Layrargues G. P. Butterworth R. F. (1989). Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.Neurochemical Research, 14(9), 853–859. 10.1007/BF009648142480534 Follow Reference Bergeron M. Swain M. S. Reader T. A. Butterworth R. F. (1995). Increased mesocortical dopaminergic function following ammonia administration to rats with portacaval anastomosis.Neurochemical Research, 10, 79–86. 10.1007/BF009951567739763 Follow Reference Brunberg J. A. Kanal E. Hirsch W. Van Thiel D. H. (1991). Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T.AJNR. American Journal of Neuroradiology, 12(5), 909–914.1950920 Follow Reference Burkhard P. R. Delavelle J. Du Pasquier R. Spahr L. (2003a). Chronic parkinsonism associated with cirrhosis: A distinct subset of acquired hepatocerebral degeneration.Archives of Neurology, 60(4), 521–528. 10.1001/archneur.60.4.52112707065 Follow Reference Burkhard P. R. Delavelle J. Du Pasquier R. Spahr L. (2003b). Chronic Parkinsonism Associated With Cirrhosis.Archives of Neurology, 60(4), 521. 10.1001/archneur.60.4.52112707065 Follow Reference Butterworth R. F. (2000). Complications of cirrhosis III. Hepatic encephalopathy.Journal of Hepatology, 32, 171–180. 10.1016/S0168-8278(00)80424-910728803 Follow Reference Butterworth R. F. (2013). Parkinsonism in cirrhosis: Pathogenesis and current therapeutic options.Metabolic Brain Disease, 28(2), 261–267. 10.1007/s11011-012-9341-723086199 Follow Reference Butterworth R. F. (2019). Hepatic Encephalopathy in Cirrhosis : Pathology and Pathophysiology.Drugs, 0123456789(S1), 17–21. Advance online publication. 10.1007/s40265-018-1017-030706423 Follow Reference Cauli O. Llansola M. Erceg S. Felipo V. (2006). Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra.Journal of Hepatology, 45(5), 654–661. 10.1016/j.jhep.2006.06.01916982110 Follow Reference Chandra S. V. (1972). Histological and histochemical changes in experimental manganese encephalopathy in rabbits.Archiv fur Toxikologie, 29(1), 29–38. 10.1007/BF003165124261594 Follow Reference Chaudhuri K. R. Healy D. G. Schapira A. H. (2006). Non-motor symptoms of Parkinson’s disease: Diagnosis and management.Lancet Neurology, 5(3), 235–245. 10.1016/S1474-4422(06)70373-816488379 Follow Reference Chaudhuri K. R. Schapira A. H. V. (2009). Non-motor symptoms of Parkinson’s disease: Dopaminergic pathophysiology and treatment.Lancet Neurology, 8(5), 464–474. 10.1016/S1474-4422(09)70068-719375664 Chen, P., Bornhorst, J., & Aschner, M. A. (2018). Manganese metabolism in humans . Academic Press. Couper, J. (1837). On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharmacol, 1 , 41–42. Follow Reference Członkowska A. Litwin T. Dusek P. Ferenci P. Lutsenko S. Medici V. Rybakowski J. K. Weiss K. H. Schilsky M. L. (2018). Wilson disease.Nature Reviews. Disease Primers, 4(1), 21. 10.1038/s41572-018-0018-330190489 Follow Reference De Virgilio A. Greco A. Fabbrini G. Inghilleri M. Rizzo M. I. Gallo A. Conte M. Rosato C. Ciniglio Appiani M. de Vincentiis M. (2016). Parkinson’s disease: Autoimmunity and neuroinflammation.Autoimmunity Reviews, 15(10), 1005–1011. 10.1016/j.autrev.2016.07.02227497913 Follow Reference Duty S. Jenner P. (2011). Animal models of Parkinson’s disease: A source of novel treatments and clues to the cause of the disease.British Journal of Pharmacology, 164(4), 1357–1391. 10.1111/j.1476-5381.2011.01426.x21486284 Follow Reference El Hiba O. Gamrani H. Chatoui H. Ahboucha S. (2013). Loss of tyrosine hydroxylase expression within the nigro-striato-cortical pathways in the cirrhotic rat: The possible restorative effect of the neurosteroid dehydroepiandrosterone sulfate.Acta Histochemica, 115(6), 637–645. 10.1016/j.acthis.2013.01.00623453752 Follow Reference Emara A. M. El-Ghawabi S. H. Madkour O. I. El-Samra G. H. (1971). Chronic manganese poisoning in the dry battery industry.Occupational and Environmental Medicine, 28(1), 78–82. 10.1136/oem.28.1.785101169 Follow Reference Fernandez‐Rodriguez R. Contreras A. De Villoria J. G. Grandas F. (2010). Acquired hepatocerebral degeneration: Clinical characteristics and MRI findings.European Journal of Neurology, 17(12), 1463–1470. 10.1111/j.1468-1331.2010.03076.x20491897 Follow Reference Ferrara J. Jankovic J. (2009). Acquired hepatocerebral degeneration.Journal of Neurology, 256(3), 320–332. 10.1007/s00415-009-0144-719224314 Follow Reference Finlayson M. H. Superville B. (1981). Distribution of cerebral lesions in acquired hepatocerebral degeneration.Brain, 104(Pt 1), 79–95. 10.1093/brain/104.1.797470846 Follow Reference Fischer J. Baldessarini R. (1971). False neurotransmitters and hepatic failure.Lancet, 298(7715), 75–80. 10.1016/S0140-6736(71)92048-44103986 Follow Reference Hanner J. S. Li K. C. Davis G. L. (1988). Acquired hepatocerebral degeneration: MR similarity with Wilson disease.Journal of Computer Assisted Tomography, 12(6), 1076–1077. 10.1097/00004728-198811000-000363183119 Follow Reference Hazell A. S. Normandin L. Norenberg M. D. Kennedy G. Yi J.-H. (2006). Alzheimer type II astrocytic changes following sub-acute exposure to manganese and its prevention by antioxidant treatment.Neuroscience Letters, 396(3), 167–171. 10.1016/j.neulet.2005.11.06416384640 Follow Reference Inoue E. Hori S. Narumi Y. Fujita M. Kuriyama K. Kadota T. Kuroda C. H. (1991). Portal-systemic encephalopathy: Presence of basal ganglia lesions with high signal intensity on MR images.Radiology, 179(2), 551–555. 10.1148/radiology.179.2.20143102014310 Follow Reference Jagmag S. A. Tripathi N. Shukla S. D. Maiti S. Khurana S. (2016). Evaluation of models of Parkinson’s disease.Frontiers in Neuroscience, 9, 503. 10.3389/fnins.2015.0050326834536 Follow Reference Jog M. S. Lang A. E. (1995). Chronic acquired hepatocerebral degeneration: Case reports and new insights.Movement Disorders, 10(6), 714–722. 10.1002/mds.8701006048749990 Follow Reference Kim J. Kim J.-M. Kim Y. K. Shin J. W. Choi S. H. Kim S. E. Kim Y. (2007). Dopamine transporter SPECT of a liver cirrhotic with atypical parkinsonism.Industrial Health, 45(3), 497–500. 10.2486/indhealth.45.49717634700 Follow Reference Kreis R. Ross B. D. Farrow N. A. Ackerman Z. (1992). Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy.Radiology, 182(1), 19–27. 10.1148/radiology.182.1.13457601345760 Follow Reference Krieger D. Krieger S. Theilmann L. Jansen O. Gass P. Lichtnecker H. (1995). Manganese and chronic hepatic encephalopathy.Lancet, 346(8970), 270–274. 10.1016/S0140-6736(95)92164-87630246 Follow Reference Krieger S. Jauß M. Jansen O. Stiehl A. Sauer P. Geißler M. Theilmann L. Krieger D. (1997). MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: Results of a controlled prospective clinical investigation.Journal of Hepatology, 27(1), 121–126. 10.1016/S0168-8278(97)80290-59252084 Follow Reference Krieger S. Jauss M. Jansen O. Theilmann L. Geissler M. Krieger D. (1996). Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis.Gastroenterology, 111(1), 147–155. 10.1053/gast.1996.v111.pm86981938698193 Follow Reference Kulisevsky J. Ruscalleda J. Grau J. M. (1991). MR imaging of acquired hepatocerebral degeneration.AJNR. American Journal of Neuroradiology, 12(3), 527.2058508 Follow Reference Lang A. E. Obeso J. A. (2004). Challenges in Parkinson’s disease: Restoration of the nigrostriatal dopamine system is not enough.Lancet Neurology, 3(5), 309–316. 10.1016/S1474-4422(04)00740-915099546 Follow Reference Layrargues G. P. (2001).. . Movement Dysfunction and Hepatic Encephalopathy., 16(June), 27–35. Follow Reference Lee J. Lacomis D. Comu S. Jacobsohn J. Kanal E. (1998). Acquired hepatocerebral degeneration: MR and pathologic findings.AJNR. American Journal of Neuroradiology, 19(3), 485–487.9541303 Follow Reference Levy V. G. Cameron E. Ollat H. Opolon P. Darnis F. Contamin F. (1983). Chronic hepatic encephalopathies. Acquired cerebral degeneration not due to Wilson’s disease. La Semaine Des Hopitaux: Organe Fonde Par L’association D’enseignement Medical L’Hôpital à Paris, 59(18), 1369–1373. Follow Reference Lockwood A. H. Yap E. W. H. Rhoades H. M. Wong W.-H. (1991). Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy.Journal of Cerebral Blood Flow and Metabolism, 11(2), 331–336. 10.1038/jcbfm.1991.661997505 Follow Reference Lunzer M. James I. M. Weinman J. Sherlock S. (1974). Treatment of chronic hepatic encephalopathy with levodopa.Gut, 15(7), 555–561. 10.1136/gut.15.7.5554430473 Follow Reference Mehkari Z. Mohammed L. Javed M. Althwanay A. Ahsan F. Oliveri F. Goud H. K. Rutkofsky I. H. (2020). Manganese, a Likely Cause of “Parkinson’s in Cirrhosis”, a Unique Clinical Entity of Acquired Hepatocerebral Degeneration.Cureus, 12(9). Advance online publication. 10.7759/cureus.1044833072457 Follow Reference Methawasin K. Chonmaitree P. Wongjitrat C. Rattanamongkolgul S. Asawavichienjinda T. (2016). Movement Disorders in Non-Wilsonian Cirrhotic Patients: A Report of the Prevalence and Risk Factors from a Study Done in a Medical School in an Agricultural-Based Community.Journal of Movement Disorders, 9(1), 28–34. 10.14802/jmd.1503426648181 Follow Reference Miletić V. Ozretić D. Relja M. (2014). Parkinsonian syndrome and ataxia as a presenting finding of acquired hepatocerebral degeneration.Metabolic Brain Disease, 29(1), 207–209. 10.1007/s11011-013-9478-z24390157 Follow Reference Moore J. W. Dunk A. A. Crawford J. R. Deans H. Besson J. A. O. De Lacey G. Sinclair T. S. Mowat N. A. G. Brunt P. W. (1989). Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis: A controlled study.Journal of Hepatology, 9(3), 319–325. 10.1016/0168-8278(89)90140-22691567 Follow Reference Morgan M. Y. Jakobovits A. W. James I. M. Sherlock S. (1980). Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy.Gastroenterology, 78(4), 663–670. 10.1016/0016-5085(80)90665-47353752 Mosher, T. J., Lacey, P. G., Barron, T. F., McNamara, K. P., & Devenyi, A. G. (1994). Increased signal intensity in the basal ganglia on T1-weighted MRI correlates with elevated erythrocyte manganese in patients with chronic liver disease. Proc. Soc. Magnetic Resonance, 1 (8). Follow Reference Mousseau D. D. Baker G. B. Butterworth R. F. (1997). Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy.Journal of Neurochemistry, 68(3), 1200–1208. 10.1046/j.1471-4159.1997.68031200.x9048767 Follow Reference Mousseau D. D. Perney P. Layrargues G. P. Butterworth R. F. (1993). Selective loss of pallidal dopamine D2 receptor density in hepatic encephalopathy.Neuroscience Letters, 162(1–2), 192–196. 10.1016/0304-3940(93)90593-A8121627 Follow Reference Noone M. Pradeep Kumar V. Ummer K. Achambat L. Salam K. (2008). Cirrhosis presenting as Parkinsonism.Annals of Indian Academy of Neurology, 11(3), 179–181. 10.4103/0972-2327.4293819893665 Norenberg, M. D. (1990). Astrocytes in hepatic encephalopathy. Cirrhosis, Hepatic Encephalopathy, and Ammonium Toxicity , 81–97. Follow Reference Ohl F. Arndt S. S. van der Staay F. J. (2008). Pathological anxiety in animals.Veterinary Journal (London, England), 175(1), 18–26. 10.1016/j.tvjl.2006.12.01317321766 Follow Reference Park H. K. Kim S. M. Choi C. G. Lee M. C. Chung S. J. (2008). Effect of trientine on manganese intoxication in a patient with acquired hepatocerebral degeneration.Movement Disorders, 23(5), 768–770. 10.1002/mds.2195718307260 Follow Reference Pentschew A. Ebner F. F. Kovatch R. M. (1963). Experimental manganese encephalopathy in monkeys: A preliminary report.Journal of Neuropathology and Experimental Neurology, 22(3), 488–499. 10.1097/00005072-196307000-0001014045007 Follow Reference Pomier-Layrargues G. Spahr L. Butterworth R. (1995). Increased manganese concentrations in pallidum of cirrhotic patients.Lancet, 345(8951), 735. 10.1016/S0140-6736(95)90909-57885158 Follow Reference Pujol A. Graus F. Peri J. Mercader J. M. Rimola A. (1991). Hyperintensity in the globus pallidus on T1‐weighted and inversion‐recovery MRI: A possible marker of advanced liver disease.Neurology, 41(9), 1526. 10.1212/WNL.41.9.15261891111 Follow Reference Pujol J. Kulisevsky J. Moreno A. Deus J. Alonso J. Balanzo J. Marti-Vilalta J. L. Capdevila A. (1996). Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy.Neurology, 47(6), 1526–1530. 10.1212/WNL.47.6.15268960739 Follow Reference Rose C. Butterworth R. F. Zayed J. Normandin L. Todd K. Michalak A. Spahr L. Huet P. Pomier–Layrargues G. (1999). Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.Gastroenterology, 117(3), 640–644. 10.1016/S0016-5085(99)70457-910464140 Follow Reference Sahney A. Sharma B. C. Jindal A. Anand L. Arora V. Vijayaraghavan R. Dhamija R. M. Kumar G. Bhardwaj A. Sarin S. K. (2019). A double-blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism.Liver International, 39(4), 684–693. 10.1111/liv.1402430554466 Follow Reference Saito H. Ejima A. (1995). Liver dysfunction and probable manganese accumulation in the brainstem and basal ganglia.Journal of Neurology, Neurosurgery, and Psychiatry, 58(6), 760–761. 10.1136/jnnp.58.6.760-a7608690 Follow Reference Shin, H., & Park, H. K. (2017). Recent Updates on Acquired Hepatocerebral Degeneration. Tremor and Other Hyperkinetic Movements , 1–12. 10.7916/D8TB1K44 Follow Reference Shin H.-W. Park H. K. (2017). Recent updates on acquired hepatocerebral degeneration.Tremor and Other Hyperkinetic Movements (New York, N.Y.), 7.28975044 Follow Reference Spahr L. Butterworth R. F. Fontaine S. Bui L. Therrien G. Milette P. C. Lebrun L. H. Zayed J. Leblanc A. Pomier‐Layrargues G. (1996). Increased blood manganese in cirrhotic patients: Relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms.Hepatology (Baltimore, Md.), 24(5), 1116–1120. 10.1002/hep.5102405238903385 Follow Reference Stadler H. (1935). Histopathologische Untersuchungen zur Frage der Beziehung zwischen Leber-und Gehirnveränderungen.Zeitschrift für die Gesamte Neurologie und Psychiatrie, 154(1), 626–657. 10.1007/BF02865820 Follow Reference Sureka B. Bansal K. Patidar Y. Rajesh S. Mukund A. Arora A. (2015). Neurologic Manifestations of Chronic Liver Disease and Liver Cirrhosis.Current Problems in Diagnostic Radiology, 44(5), 449–461. 10.1067/j.cpradiol.2015.03.00425908229 Follow Reference Tarter R. Sandford S. Hays A. Van Thiel D. (1986). Cerebral morphological abnormalities associated with non-alcoholic cirrhosis.Lancet, 328(8512), 893–895. 10.1016/S0140-6736(86)90413-72876329 Follow Reference Taylor-Robinson S. D. Oatridge A. Hajnal J. V. Burroughs A. K. McIntyre N. deSouza N. M. (1995). MR Imaging of the basal ganglia in chronic liver disease: Correlation of T 1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status.Metabolic Brain Disease, 10(2), 175–188. 10.1007/BF019918647675015 Follow Reference Taylor-Robinson S. D. Sargentoni J. Marcus C. D. Morgan M. Y. Bryant D. J. (1994). Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy.Metabolic Brain Disease, 9(4), 347–359. 10.1007/BF020988817898401 Follow Reference Thuluvath P. J. Edwin D. Yue N. C. Devilliers C. Hochman S. Klein A. (1995). Increased signals seen in globus pallidus in Tl-weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy.Hepatology (Baltimore, Md.), 21(2), 440–442. 10.1016/0270-9139(95)90105-17843718 Follow Reference Toghill P. J. Johnston A. W. Smith J. F. (1967). Choreoathetosis in porto-systemic encephalopathy.Journal of Neurology, Neurosurgery, and Psychiatry, 30(4), 358–363. 10.1136/jnnp.30.4.3586055345 Follow Reference Tryc A. B. Goldbecker A. Berding G. Rümke S. Afshar K. Shahrezaei G. H. Pflugrad H. Barg-Hock H. Strassburg C. P. Hecker H. Weissenborn K. (2013). Cirrhosis-related Parkinsonism: Prevalence, mechanisms and response to treatments.Journal of Hepatology, 58(4), 698–705. 10.1016/j.jhep.2012.11.04323220368 Follow Reference Tuschl K. Mills P. B. Clayton P. T. (2013). Manganese and the Brain. In Metal Related Neurodegenerative Disease (1st ed., Vol. 110). Elsevier Inc.10.1016/B978-0-12-410502-7.00013-2 Follow Reference Van Woerkem W. (1914). La cirrhose hepatique avec alterations dans les centres nerveux evoluant chez des sujets d’age moyen. Nouvelle Iconographie de La Salpetriere . Clinique Des Maladies Du Systeme Nerveux, 7, 41–45. Follow Reference Victor M. Adams R. D. Cole M . (1965). The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration.Medicine, 44(5), 345–396. 10.1097/00005792-196509000-000015318075 Follow Reference Wang J. D. Huang C. C. Hwang Y. H. Chiang J. R. Lin J. M. Chen J. S. (1989). Manganese induced parkinsonism: An outbreak due to an unrepaired ventilation control system in a ferromanganese smelter.Occupational and Environmental Medicine, 46(12), 856–859. 10.1136/oem.46.12.8562611159 Follow Reference Weissenborn K. Ehrenheim C. Hori A. Kubicka S. Manns M. P. (1995). Pallidal lesions in patients with liver cirrhosis: Clinical and MRI evaluation.Metabolic Brain Disease, 10(3), 219–231. 10.1007/BF020810278830282 Follow Reference Weissenborn K. Kolbe H. (1998). The basal ganglia and portal-systemic encephalopathy.Metabolic Brain Disease, 13(4), 261–272. 10.1023/A:102062860724510206819 Follow Reference Wilson S. A. K. (1971). Progressive lenticular degeneration: A familial nervous disease associated with cirrhosis of the liver.Archives of Neurology, 25(2), 180–186. 10.1001/archneur.1971.00490020098013 Follow Reference Yang, H. J., Park, S. H., Seo, M., Weon, Y. C., & Kim, Y. (2018). 18 F-FP-CIT dopamine transporter PET findings in cirrhotic patients with parkinsonism. NeuroToxicology, 64 (2016), 78–84. 10.1016/j.neuro.2017.02.014 Follow Reference Zeneroli M. L. Cioni G. Crisi G. Vezzelli C. Ventura E. (1991). Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: An MR imaging study.Magnetic Resonance Imaging, 9(3), 295–302. 10.1016/0730-725X(91)90414-H1881246